Last reviewed · How we verify
HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers
To evaluate the safety, tolerability and pharmacokinetics of HEC53856 after single or multiple oral administration, as well as the food effect on the pharmacokinetics, in healthy non-elderly subjects.
Details
| Lead sponsor | Sunshine Lake Pharma Co., Ltd. |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 116 |
| Start date | Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Jan 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Healthy
Interventions
- HEC53856
- placebo
Countries
China